Somite

Somite is developing AI foundation models to produce human tissue at scale for cell therapies. Its AlphaStem AI platform aims to improve the efficiency, scalability, and robustness of existing cell therapy protocols, addressing challenges in producing various human cell types for treating diseases like diabetes, obesity, and muscular dystrophies. The company leverages a digital twin of the embryo to optimize cell production.

Funding Round: Pre-Seed

Funding Amount: $5.3M

Date: 16-Apr-2024

Investors: TechAviv, Next Coast Ventures, Trust Ventures, Texas Venture Partners, Lerer Hippeau

Markets: AI, Biotech, Healthtech, Cell Therapy

HQ: Boston, Massachusetts, United States

Founded: 2023

Website: https://somite.ai/

LinkedIn: https://www.linkedin.com/company/somite-therapeutics

Twitter: https://twitter.com/SomiteAi

Instagram:

Facebook: